Sick Day with Diabetes
"Sick-day rules" center on never stopping insulin, more frequent glucose and ketone monitoring, aggressive hydration/carbohydrate intake, and temporarily holding certain oral/injectable agents that risk dehydration, AKI, lactic acidosis, or euglycemic DKA. The overarching principle for insulin-treated patients—especially type 1 diabetes—is that basal insulin must never be discontinued even when the patient is not eating, because counter-regulatory stress hormones drive hyperglycemia and ketogenesis regardless of oral intake.[1][2]
Monitoring during illness
- Check capillary glucose every few hours (roughly every 2-4 h, or every 6 h at minimum), and check blood or urine ketones at least twice daily in ketosis-prone patients.[1][3]
- Maintain adequate fluids and carbohydrate intake; if unable to eat solids, substitute carbohydrate-containing fluids.[2][1]
- Seek urgent care for persistent vomiting, inability to keep fluids down, reduced consciousness, significant ketosis, tachycardia, or hypotension—these signal impending DKA or volume depletion.[4][1]
Insulin adjustment
- Never stop basal insulin in type 1 diabetes (and insulin-requiring type 2), even with poor oral intake.[1][2]
- For hyperglycemia/ketosis, increase insulin: consensus guidance recommends raising basal and bolus insulin by 10-20% based on glucose trends, with supplemental correction (rapid-acting) doses for ketones.[4][5]
- For GI upset with reduced intake but feeling otherwise well, the prandial/bolus component may need reduction to avoid hypoglycemia while continuing basal.[5][2]
- Devise an individualized written sick-day plan in advance, specifying monitoring, insulin titration, and escalation triggers.[2][3]
Non-insulin agents to hold ("SADMANS"-type medications)
The 2026 ADA Standards and Delphi consensus recommend temporarily withholding several agents during acute illness with reduced intake or volume depletion:
- Metformin — hold if oral intake cannot be maintained, with concern for AKI, or hypoperfusion/hypoxemia (lactic acidosis risk).[3][4]
- SGLT2 inhibitors — hold during acute illness due to dehydration and euglycemic DKA risk.[3][6]
- GLP-1 receptor agonists — hold for illnesses with significant GI symptoms or hemodynamic instability.[3][7]
- Thiazolidinediones — hold in heart failure exacerbation or hypervolemic states.[3]
- Sulfonylureas/meglitinides — hold only if glucose is low; also temporarily reduce/stop when starting interacting antimicrobials (fluoroquinolones, clarithromycin, sulfamethoxazole-trimethoprim, metronidazole, fluconazole) that potentiate hypoglycemia.[3][4]
- Non-diabetes agents typically co-held: ACE inhibitors/ARBs, diuretics, and NSAIDs (AKI risk).[4][8]
Resumption. Restart held medications within 24-48 hours of symptom resolution once normal eating and drinking resume; explicit counseling on restarting is critical, as failure to resume beneficial agents is a common error.[4][8]
Hospitalized / severe stress. When illness requires admission or oral agents are stopped, transition to insulin. For non-critically ill patients, a glycemic target of 100-180 mg/dL is recommended, and basal-bolus regimens are preferred over sliding-scale insulin alone.[9][10] For glucocorticoid-induced hyperglycemia, NPH timed to the steroid dose (≈0.1 units/kg/day per 10 mg prednisone) is a practical strategy, and patients already on insulin often need a 20-40% total daily dose increase.[10]
The following table summarizes practical insulin adjustments by diabetes type and oral intake status in the hospitalized/stressed patient:
Would you like to explore management of glucocorticoid-induced hyperglycemia in more detail?
References
  1. Diabetic ketoacidosis. Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Nature Reviews. Disease Primers. 2020;6(1):40. doi:10.1038/s41572-020-0165-1.
  2. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Holt RIG, DeVries JH, Hess-Fischl A, et al. Diabetologia. 2021;64(12):2609-2652. doi:10.1007/s00125-021-05568-3.
  3. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care. 2026;49(Supplement_1):S132-S149. doi:10.2337/dc26-S006.
  4. Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process. Watson KE, Dhaliwal K, Robertshaw S, et al. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2023;81(5):564-574. doi:10.1053/j.ajkd.2022.10.012.
  5. A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes. Forst T, Choudhary P, Schneider D, Linetzky B, Pozzilli P. Diabetes/Metabolism Research and Reviews. 2021;37(6):e3418. doi:10.1002/dmrr.3418.
  6. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). de Boer IH, Khunti K, Sadusky T, et al. Diabetes Care. 2022;45(12):3075-3090. doi:10.2337/dci22-0027.
  7. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Katulanda P, Dissanayake HA, Ranathunga I, et al. Diabetologia. 2020;63(8):1440-1452. doi:10.1007/s00125-020-05164-x.
  8. Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines. Mayne KJ, Hanlon P, Lees JS. Diabetes, Obesity & Metabolism. 2024;26 Suppl 6:43-54. doi:10.1111/dom.15625.
  9. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026. American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care. 2026;49(Supplement_1):S339-S355. doi:10.2337/dc26-S016.
  10. Managing Selected Chronic Conditions in Hospitalized Patients. Robert L. Gauer, MD, Alain Abellada, MD, Matthew Stewart, MD, et al. American Family Physician. 2024.
0
0 comments
Elven Smith
1
Sick Day with Diabetes
powered by
skool.com/elven-conrad-smith-5531
MISSION: SAVE 1 MILLION CHILDREN FROM RAVAGES OF DIABETES
Build your own community
Bring people together around your passion and get paid.
Powered by